A gaggle of 12 Democratic state attorneys basic despatched a letter to the Drug Enforcement Administration (DEA) on Friday to reschedule hashish from Schedule I to Schedule III of the Managed Substances Act (CSA).
Rescheduling marijuana is “the following step in the transfer in the direction of a extra accountable hashish coverage,” they wrote in a letter to DEA Administrator Anne Milgram on Friday.
At present, hashish is classed as a Schedule I substance alongside harmful medication like heroin and LSD, and rescheduling will see it transferring to Schedule III, a low-risk class for medicines like Tylenol and ketamine.
Led by Colorado Lawyer Basic Phil Weiser, the group highlighted the U.S. Division of Well being and Human Companies’ (HHS) current advice for rescheduling “in the interest of public health and safety.”
“For these causes, we encourage the DEA to implement a final rule rescheduling hashish to Schedule III primarily based on the Federal Drug Administration’s scientific and medical conclusions,” they added.
“We see this as a public security crucial and write in help of this coverage change.” The group represented attorneys basic from Colorado, California, Connecticut, Delaware, Illinois, Maryland, Massachusetts, Nevada, New Jersey, Pennsylvania, Oregon, and Rhode Island.
In December, governors of six states collectively wrote a letter to President Joe Biden, urging the administration to make sure marijuana was rescheduled by the top of final yr.
Early this month, hashish shares rallied amid stories that the DEA was conducting its review for rescheduling.
U.S. MSOs: MedMen Enterprises (OTCQB:MMNFF), Curaleaf Holdings (OTCPK:CURLF), Acreage Holdings (OTCQX:ACRHF), Cresco Labs (OTCQX:CRLBF), Inexperienced Thumb Industries (OTCQX:GTBIF), Trulieve Hashish (OTCQX:TCNNF), Ayr Wellness (OTCQX:AYRWF), TerrAscend (OTCQX:TSNDF), Intelligent Leaves (CLVR), Flora Development (FLGC)
Canadian Licensed Producers: Cover Development (CGC), Tilray (TLRY), Cronos (CRON), Aurora Hashish (ACB), SNDL Inc. (SNDL), OrganiGram Holdings (OGI)
Extra on Acreage Holdings, Cresco Labs, and so on.
A gaggle of 12 Democratic state attorneys basic despatched a letter to the Drug Enforcement Administration (DEA) on Friday to reschedule hashish from Schedule I to Schedule III of the Managed Substances Act (CSA).
Rescheduling marijuana is “the following step in the transfer in the direction of a extra accountable hashish coverage,” they wrote in a letter to DEA Administrator Anne Milgram on Friday.
At present, hashish is classed as a Schedule I substance alongside harmful medication like heroin and LSD, and rescheduling will see it transferring to Schedule III, a low-risk class for medicines like Tylenol and ketamine.
Led by Colorado Lawyer Basic Phil Weiser, the group highlighted the U.S. Division of Well being and Human Companies’ (HHS) current advice for rescheduling “in the interest of public health and safety.”
“For these causes, we encourage the DEA to implement a final rule rescheduling hashish to Schedule III primarily based on the Federal Drug Administration’s scientific and medical conclusions,” they added.
“We see this as a public security crucial and write in help of this coverage change.” The group represented attorneys basic from Colorado, California, Connecticut, Delaware, Illinois, Maryland, Massachusetts, Nevada, New Jersey, Pennsylvania, Oregon, and Rhode Island.
In December, governors of six states collectively wrote a letter to President Joe Biden, urging the administration to make sure marijuana was rescheduled by the top of final yr.
Early this month, hashish shares rallied amid stories that the DEA was conducting its review for rescheduling.
U.S. MSOs: MedMen Enterprises (OTCQB:MMNFF), Curaleaf Holdings (OTCPK:CURLF), Acreage Holdings (OTCQX:ACRHF), Cresco Labs (OTCQX:CRLBF), Inexperienced Thumb Industries (OTCQX:GTBIF), Trulieve Hashish (OTCQX:TCNNF), Ayr Wellness (OTCQX:AYRWF), TerrAscend (OTCQX:TSNDF), Intelligent Leaves (CLVR), Flora Development (FLGC)
Canadian Licensed Producers: Cover Development (CGC), Tilray (TLRY), Cronos (CRON), Aurora Hashish (ACB), SNDL Inc. (SNDL), OrganiGram Holdings (OGI)